CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
1K
Total Open
Publications
515
Total
Citations
30K
Open Access
Percentage
51%
Total
Publications
1K
Total Open
Publications
515
Total
Citations
30K
Breakdown
Publisher Open
21%
Both
25%
Other Platform Open
4%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
172
Hybrid 27%
126
No Guarantees 36%
163
Other Platform Open
Domain 74%
222
Institution 38%
113
Other Internet 18%
53
Preprint 5%
16
Public 2%
7
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 222 |
DOI | Other Internet | 43 |
DANS - Data Archiving and Networked Services | Institution | 21 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 17 |
Europe PMC | Domain | 15 |
arXiv | Preprint | 12 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 11 |
Unknown Repository | Other Internet | 10 |
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB | Institution | 6 |
KU Leuven - Lirias | Institution | 6 |